Capital Empowerment: Bio-AI Drives a New Ecosystem for Life Sciences

Challenges and Opportunities of AI in Life Sciences Research

Lu Tao, Professor, Doctoral Supervisor, Special Researcher at the National Academy of Chinese Medicine Strategy and Development, Beijing University of Chinese Medicine; Special Professor at the School of Life Sciences; Director of the Integrative Medicine Center

Capital Empowers Industry Development: Bio-AI Convergence and Innovation

Shan Junbao, Chairman of CICC Capital

AI-Driven R&D of Biomedical Materials

Li Zhiyi, EPSRC Researcher at the University of Cambridge; Dual PhD from TU Darmstadt and Université libre de Bruxelles; EU Marie Curie Fellow; Recipient of the Belgian Solvay Prize; AI Engineer at Graphcore; LLM/NLP Scientist; Head of Applied AI/Machine Learning

The 'Future' of the Future Has Arrived

Ma Ruihao: A 15-year-old student from Beijing Academy International Division; Enthusiast of invention, programming, and robotics; Multiple award winner in youth innovation competitions; Core member of the 2024 VEX Robotics Team, responsible for robot construction and autonomous programming; Qualified for the CREATE U.S. Open

Panel Discussion 1: Insights and Capital Methodologies of Young Investors

Moderator: Liu Dan, Pivotal bioVenture China Managing Partner/H50 Youth Council Member

Panelists:

1. Chen Lei, Founding Partner of Boxing Capital/H50 Youth Council Member

2. Gao Jieliang, Senior Partner of CDH Innovation and Growth Fund/H50 Youth Council Member

3. Jiang Houjia, Founding Partner of Hongsheng Capital/H50 Youth Council Member

4. Lin Lei, Chairman of CCB International Healthcare Growth Fund/H50 Youth Council Member

5. Tang Yinglong, Deputy General Manager of CICC Qide Fund/H50 Youth Council Member

6. Wei Yaguang, Partner of Guofang Innovation/H50 Youth Council Member

7. Zhang Chong, Partner of Songhe Capital/H50 Youth Council Member

Panel Discussion 2: What Shocks the World About China Is Not Just AI

Moderator: Yang Ruirong, Partner of Yuan Capital, H50 Council Member/2020 Rotating Chair

Panelists:

1. Cui Jisong, Co-founder, Chairman, and CEO of InnoCare Pharma

2. Jiang Linjie, Chairman of Singularity Holdings and Lingxi Technology

3. Kang Linhui, General Manager of Hongmo Biotechnology

4. Qin Lan, Founder and Chairman of StrongLink Intelligence

5. Qin Yong, COO of Airdoc

6. Shen Yiguang, General Manager of China Medical and Pharmaceutical Emergency Support Platform Co., Ltd.

7. Zhang Yu, Founding Partner of Qingzhi Capital

Panel Discussion 3: Breaking Barriers in the Transformation of Scientific and Technological Achievements

Moderator: Cai Daqing, Founding Managing Partner of Sherpa Healthcare Partners, H50 Council Member/2019 Rotating Chair

Panelists:

1. Li Ning, Former President of Beijing You’an Hospital, Capital Medical University

2. Li Xuhui, Director of the Analytical Testing Center, Zhejiang Tsinghua Yangtze Delta Research Institute

3. Leng Zhiwei Deputy Researcher and Director of the Health Policy and Economics Platform, National Translational Medicine Research Facility, Peking Union Medical College Hospital

4. Wang Xiaojian, Researcher at Fuwai Hospital, Chinese Academy of Medical Sciences; Professor and Doctoral Supervisor at Peking Union Medical College; Principal Investigator at the National Key Laboratory of Cardiovascular Diseases

5. Wang Jiangang, General Manager and Chief Scientist of Kanglitai Pharmaceuticals

6. Wang Ying, General Manager of Beijing Changping Science Park Development Co., Ltd., H50 Council Member/2023 Rotating Chair

7. Zhao Jinjun, Head of the Stem Cell Platform, Peking Union Medical College Hospital; Chairman of Hexie Technology Co., Ltd.